Selank for sale looks like a product page and behaves like a form. Honest listings fill in the same set of fields, dishonest ones leave the same fields blank, and the gap between them is easier to read than any review, especially at the end of a week where the training has been holding on by adherence.
Key takeaways
- Six fields decide a listing: form, quantity, lot number, storage, testing scope and compliance language. A page missing three of them is not a bargain, it is an unfinished product page.
- A lot number is the field that makes everything else checkable, because it is what ties a certificate to the vial in the box.
- The listing covered here publishes an assayed quantity of 12.29 mg against a 10 mg label on one lot and 11.86 mg on another. Publishing a number that can be measured against you is rare and worth crediting.
- Testing scope on the same product changed between those two lots. The February certificate stops at identity, purity and quantity. The June certificate adds endotoxin, sterility and heavy metals.
- FDA's stated concern is immunogenicity from aggregation and peptide-related impurities, which is why testing scope is the field to read last and weigh first.
The listing being read field by field below is this one, and the numbers belong on the table before the analysis rather than after it.
The vendor we point lifters to
Selank from Ascension Peptides
Independently assayed material, dispatched from the US. The vial drops by half with the code below.
The published certificate for lot 29-01260229 assays this vial at 12.29 mg against a 10 mg label, and reports no endotoxin or sterility testing. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Two independent lab reports per batch
- Free delivery above $250
- Same-day dispatch on orders before 2pm CST
Research material, laboratory use only, not for human consumption. Affiliate links: we may earn a commission at no extra cost to you. Pricing verified August 21, 2026.
Selank for sale: the six fields, and what each one is hiding when it is blank
| Field | What a real listing states | What the omission means |
|---|---|---|
| Form | Lyophilised powder, or a solution, said plainly | You do not know what arrives or how it must be kept |
| Quantity | A milligram figure per vial, not per spray or per bottle | Nothing can be priced, compared or checked |
| Lot number | A specific lot, matching the certificate offered | The certificate belongs to some other material |
| Storage | Conditions for the sealed product, stated by the seller | Nobody has taken responsibility for the cold chain |
| Testing scope | Which tests were run, not a badge saying "tested" | Purity was measured and the harder questions were skipped |
| Compliance language | Research use only, no amounts, no benefit claims | The seller treats the rules as optional, including the ones about what is in the vial |
The lot number is the load-bearing field. Everything else on a listing is a claim; a lot number is a claim you can take to a document. A page offering "COA available on request" without a lot is offering a PDF, not evidence, and the two are easy to confuse when you are tired.
Form and quantity, where the spray listings quietly fail
Search "selank nasal spray for sale" alongside "selank vials for sale" and the results are not competing offers on the same product. Research suppliers sell lyophilised powder in a sealed vial with a milligram figure on the label. Nootropic retailers sell a solution in a pump bottle.
The failure mode is specific to the spray listings, and it is the quantity field. Content is sometimes stated per bottle, sometimes per spray, and often not stated in milligrams at all. When it is missing, there is no per-milligram price, no way to compare two sprays against each other, and nothing for a certificate to be checked against even if one existed.
Form also changes what storage means. A sealed lyophilised powder and a room-temperature solution in a pump bottle carry different microbial and stability burdens, and that burden sits with the seller. The buyer's only window into it is the testing scope field, which brings us to the part that decides the purchase.
The quantity field, and the number worth checking
This is the field where the listing covered here does something unusual, and it is worth walking through rather than asserting.
Selank is a synthetic heptapeptide, seven residues, Thr-Lys-Pro-Arg-Pro-Gly-Pro, an analogue of the immune peptide tuftsin with a Pro-Gly-Pro tail added to slow enzymatic breakdown. PubChem CID 11765600 lists the formula as C33H57N11O9 and the molecular weight as 751.9. Those figures are public, which means a certificate can be wrong in a way anyone can detect.
Ascension's Selank 10 mg publishes two batch reports rather than one, and they say different things.
The MZ Biolabs certificate for lot 29-01260229, analysis date 2026-02-07 and report date 2026-02-13, is two pages. Purity is 99.32% by HPLC-UV, with the chromatogram and a two-peak list shown rather than summarised. Identity is confirmed by mass spectrometry: expected monoisotopic mass 751.43 Da, measured 751.47 Da. Quantification by HPLC-UV gives measured quantity of 12.29 mg per vial against a 10 mg label.
The Kovera Labs certificate for lot 29-05260628, certified 06/02/2026, is four pages. Purity 99.371%, identity by LC-MS, net content 11.86 mg against the same 10 mg label, a bacterial endotoxin result below 0.20 EU/mL against a stated limit of 0.5 EU/mL, a rapid sterility screen showing no growth, and an ICP-MS heavy metals panel returning negative for arsenic, cadmium, lead and mercury.
Two things follow. First, the overfill is real on both lots and it is lot-specific, which is exactly how it should be read. A measured 12.29 mg is a measurement of one batch, not a promise about the vial that arrives at your door, and a seller who turned it into a marketing guarantee would have overstated their own document. Publishing a number that can be measured against you at all is the unusual part, and most listings in this market do not.
Second, and more importantly for anyone deciding today: testing scope changed between those lots. Search the February document for endotoxin, LAL, pyrogen or sterility and there is nothing in it. The June document has all of it. So "does this seller test for endotoxin" is the wrong question to put to any vendor. The right one is what the certificate for the lot they are about to ship covers.
One detail inside the Kovera report deserves a mention rather than a quiet pass: the endotoxin section is headed as a kinetic chromogenic LAL assay while its own methodology table lists the assay type as kinetic turbidimetric at 660 nm. Both are recognised approaches under USP Chapter 85. A report should still agree with itself, and noticing that is the same skill as noticing a missing lot number.
The testing scope field, and why it outranks purity
FDA's concern about Selank is documented, specific, and about manufacturing rather than pharmacology. From the agency's safety risks page, content current as of 04/22/2026:
"Compounded drugs containing selank acetate may pose risk for immunogenicity for certain routes of administration due to the potential for aggregation and peptide-related impurities. FDA lacks important information regarding any safety issues raised by selank acetate administered to humans."
Aggregation and peptide-related impurities are consequences of synthesis, handling and storage. A high purity figure is evidence about one of those questions and silence about the others. Endotoxin in particular is bacterial debris rather than living organisms, it persists after the bacteria are gone, and it is measured by its own compendial assay. No chromatogram detects it, however clean.
That is why the testing scope field is the last one to read and the first one to weigh. A listing that publishes purity and stops has answered the easiest question on the sheet.
The same field-by-field discipline applied to compounds with different documented failure modes is in reading an NAD+ listing, where the problem was food-grade material reaching sterile preparations, and what each BPC-157 format means, where format rather than testing does most of the damage.
The compliance field, read correctly
Research-use language on a listing is not a loophole notice. It is a description of what the seller is allowed to say, and the things they decline to say are informative.
A compliant page states research use only, gives no amounts, offers no reconstitution guidance, makes no benefit claims and shows no before and after images. When a seller volunteers protocols or health outcomes, they have told you which rules they treat as optional, and rules about what goes in the vial are in the same category as rules about what goes on the page.
It is also worth stating plainly what no listing can supply. Selank holds no FDA approval for any indication. It was nominated as a bulk substance for compounding, sat in category 2 under FDA's interim policies during evaluation, and the nomination was withdrawn by the nominator, leaving it on no current 503A category list. It carries a Russian anxiolytic registration, which is a foreign registration and not evidence by Western regulatory standards. There is no finished Western efficacy trial in healthy trained people, and the registered trial record is the check on any listing implying otherwise.
For a lifter reading product pages at the end of a heavy block, that is the honest frame: a good listing settles what is in the container, and the things actually eroding the block are covered in sleep, cortisol and myostatin.
Frequently asked questions
What separates a real Selank listing from a fake one?
Fields, not tone. A real listing states the form, a milligram quantity, a lot number, storage conditions and which tests were run, and it carries research-use language with no amounts. Fake listings typically state a price, a purity claim, and very little else that can be checked.
Why is the assayed 12.29 mg on a 10 mg vial interesting?
Because it is a published number that can be measured against the seller. The MZ Biolabs certificate for lot 29-01260229 reports 12.29 mg by HPLC-UV quantification against a 10 mg label, and the Kovera Labs certificate for lot 29-05260628 reports 11.86 mg. Both are lot-specific measurements rather than guarantees about a future vial.
Does a certificate showing 99% purity mean the vial is safe to inject?
No, and the two questions are measured by different instruments. Purity and identity come from HPLC and mass spectrometry. Bacterial endotoxin is measured by its own assay and is invisible to both. FDA's stated concern with Selank is immunogenicity from aggregation and peptide-related impurities, which is why endotoxin testing is the field that matters most for anything injected.
Why do Selank nasal spray listings look cheaper?
Usually because they are not priced in the same unit. Sprays are sold per bottle, sometimes with content stated per spray and sometimes not stated in milligrams at all. Without a milligram figure there is no per-milligram price, so the comparison against a 10 mg vial is not a comparison.
Should I ask a seller for the certificate before buying?
Yes, and ask for it by lot. A certificate with no lot number on it is a document rather than evidence about your vial. A seller who replies with a lot number and a report covering identity, purity and endotoxin has answered properly; one who replies with reassurance has not.
Sources
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks, FDA
- Bulk Drug Substances Used in Compounding Under Section 503A, FDA
- Selank, PubChem CID 11765600
- Certificate of analysis, Selank lot 29-01260229, MZ Biolabs
- Certificate of analysis, Selank lot 29-05260628, Kovera Labs
- Registered studies of Selank, ClinicalTrials.gov
This article is for educational purposes only and is not medical advice. Selank holds no FDA approval for any indication, material sold by research suppliers is labeled for laboratory use only and not for human consumption, and a foreign registration is not an FDA approval or evidence of efficacy by Western regulatory standards. Speak with a qualified healthcare professional before making any decision involving peptides, injections or off-label compounds.